PATENT CLAIM ANALYSIS

Application Number: 15906352
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "450000"]

Abstract:
A liquid crystalline drug delivery system for ocular administration. The drug delivery system, which is mucoadhesive, biocompatible, non-irritating, and tissue permeable, contains nanoparticles stably dispersed in an aqueous solution and can be formulated for sustained release. Also provided are methods for producing the drug delivery system and methods for treating ocular disorders by administering it to a subject.

Claim (Index 22):
A method for treating an ocular disorder in a subject, the method comprising identifying a subject having an ocular disorder and administering to an eye of the subject the liquid crystalline drug delivery system of  claim 12 .

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.40426
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15308000', '15660470', '15509083', '12398657', '14399780']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7071166218707527
- 35 USC 102 Novelty (BERT): 0.552367275935984
- Combined Prediction Score: 0.6916416872772759
- Mean Citation Score: 241.6827
- Max Citation Score: 430.7722
- Similarity Product: 320.3443710119843

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test